Topiramate and Severe Obesity

PHASE3CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

June 1, 2016

Primary Completion Date

December 21, 2017

Study Completion Date

January 23, 2018

Conditions
Obese Children and Adolescents
Interventions
DRUG

Topiramate

Topiramate for 9 months treatment, and then 27 months of follow-up Dose regimen will be determined according to theoretical weight (taken orally), escalated every 15 days. Patients who do not tolerate dose escalation will be reduced to the highest tolerated dose.

DRUG

Placebo

Placebo will be taken orally following to the same dose regimen according to theoretical weight

Trial Locations (1)

94275

Hopital Bicêtre, Le Kremlin-Bicêtre

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02273804 - Topiramate and Severe Obesity | Biotech Hunter | Biotech Hunter